Lucas Schalch Email & Phone Number

Pratteln, Basel-Country, Switzerland

Time to take a break and filling the batteries before starting a new challenging position as per November 1st, 2022

Altstetten, Kanton Zürich, Schweiz

Tasks:- Member of the board and overall responsibility (P&L, sales, marketing, medical and market access) for the Swiss affiliate of Daiichi Sankyo with 24 employees- Cross functional leadership role for marketing, medical, market access, sales and administration- Company representative in the industry associationAchievements- Building up an oncology department and coordinate the pre-launch and launch activities for Enhertu (trastuzumab deruxtecan)- Implementing a successful alliance with Astra Zeneca in oncology- Developing a concept enabling early patient access to Enhertu, generating 0.5 million CHF sales before Swiss marketing authorization for Enhertu- Launching bempedoic acid (best uptake in Europe) a new lipid lowering therapy with an innovative mode of action in the highly competitive lipid lowering market- Coordination of the office move of Daiichi Sankyo Switzerland into new offices in Zürich area

Basel Area, Switzerland

Tasks- Board and local management team member- Full P&L responsibility for the Rx department - Leading a team (n = 8) of marketers, market access and administration- Building up a specialty business unit active in oncology and a rare lung disease (IPF)- Implementation and translation of the company wide product strategies locally- Supervising and active involvement in the reimbursement negotiations for the new pharmaceuticalsMain achievements:- Successful launches (becoming Nr. 1 drug for the treatment of EGFR+ NSCLC and for IPF)- Third in class launch of Empagliflozin. Becoming n°1 SGLT2 inhibitor 1 year following market entry

Tasks:- Member of the local management team- Building-up the market access team with 6 employees in Switzerland - Supervision and deep involvement in pricing and reimbursement for a broad portfolio covering indications such as: cardiovascular, metabolic, pain, rheumatology, virology, transplantation medicine and oncology - PR responsible for the local affiliateMain achievements:- Getting reimbursement for Yervoy (ipilimumab) 6 months ahead of plan - Coordination of ipilimumab value dossier development in EU small to mid-size countries

Tasks:- Full P&L responsibility for the business unit- Managing a team with 35 sales representatives, 3 front line managers and 6 marketeers- Compliance officer in collaboration with the local medical directorMain achievements:- Outstanding alliance/conflict management of three alliances with Sanofi, Astra Zeneca and Pfizer- Successful commercialization of three top ten products in the cardiovascular field (pravastatin, irbesartan and clopidogrel) with peak sales of 130 MM CHF- Lead the cultural change to a 100% compliant organization within 1 year

Tasks:- General manager and president of the board of directors- Full P&L responsibility for revenue of 15 MM CHF - Managing a diverse team with 27 employees, active in R&D, production, marketing and sales- Business development in close collaboration with external partners and with Intevet/Akzo Nobel- Supervision and organization of local divestment process of Dr. Bommeli AG in 2004Main achievements:- Successful expansion in EU, Latin America and South East Asia growing revenue from 4 to 11 MM CHF within 5 years- Succeeded to maintain the EU headquarter of Idexx lifestock division in Switzerland following the divestment (Idexx closed the Swedish office)

Tasks:- Management of subsidiaries and third-party distributors abroad- Building-up new distribution structures internationally- Launching new diagnostic assaysMain achievements:- Successful marketing authorization of the Classical Swine Fever Test in France and Spain, countries in which the main competitor was the state reference laboratory

Tasks:- Full marketing responsibility for the POL business with a revenue of 60 million CHFMain achievements:- Market introduction of a complete hematology analyzer portfolio (Cell-Dyne) ranging from small POL apparatus to large scale university hospital analyzers, reaching sales of 5 million CHF in the 1st year

Executive Mba, Rochester/Bern Executive Mba

Phd Thesis, Immunology

Dvm, Veterinary Medicine